Federated Hermes, Inc. Meira G Tx Holdings PLC Transaction History

Federated Hermes, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$13.42 - $23.38 $590 - $1,028	-44 Reduced 0.1%	45,557 $631,000
Q4 2021 Feb 14, 2022	SELL	$12.78 - $23.74 $7,808 - $14,505	-611 Reduced 1.32%	45,601 $1.08 Million
Q3 2021 Nov 15, 2021	SELL	$11.73 - $16.08 $23,108 - $31,677	-1,970 Reduced 4.09%	46,212 $609,000
Q2 2021 Aug 16, 2021	SELL	$12.85 - $16.2 $783 - $988	-61 Reduced 0.13%	48,182 $747,000
Q1 2021 May 13, 2021	BUY	$13.84 - $17.8 $667,683 - $858,725	48,243 New	48,243 $696,000
Q4 2019 Feb 14, 2020	SELL	$13.91 - $21.48 $997,249 - $1.54 Million	-71,693 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$15.84 - $30.01 $258,334 - $489,433	-16,309 Reduced 18.53%	71,693 $1.14 Million
Q2 2019 Aug 14, 2019	BUY	$17.38 - $26.88 $1.53 Million - $2.37 Million	88,002 New	88,002 $2.37 Million

39.7M

24.2K

30.7K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $192M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.